CDC’s Immunization Safety Office is pleased to offer a free online continuing education (CME and CE) activity on Medscape titled, “Real Talk About Influenza Vaccine Safety – Be Informed and Be Prepared.” The CME/CE features a roundtable discussion with three vaccine safety and influenza prevention experts. The course is intended for clinicians who routinely administer influenza vaccines and who evaluate and treat patients experiencing adverse events following influenza immunization. Healthcare providers interested in this course may include physicians, nurses, physicians assistants, and nurse practitioners in family medicine, internal medicine, pediatrics, and obstetrics/gynecology.
The 30-minute, web-based program is designed to educate clinicians about the following:
The safety profiles of licensed influenza vaccines.
Safe administration of influenza vaccines and screening for contraindications and precautions.
Resources available for communicating benefits and risks of influenza vaccination.
Accurate and timely reporting of any adverse events to the
Vaccine Adverse Event Reporting System (VAERS). To participate in this free
CME/CE activity, please visit
www.cdc.gov/vaccinesafety and click on the quick links to the course.
To view the popular
CDC Expert Commentary Series on Medscape, please visit
http://www.medscape.com/partners/cdc/public/cdc-commentary.
CDC Expert Commentary
This special series of commentaries is part of a collaboration between CDC and Medscape and is designed to deliver CDC's authoritative guidance directly to Medscape's physicians, nurses, pharmacists, and other healthcare professionals. In this series, experts from CDC offer video commentaries on the current topics important to all practicing clinicians, including H1N1 and seasonal influenza, infection control, travel medicine, and much more.
- Hey Doc, When Can I Return to Play? Managing sports-related concussion involves more than acute care; a step-wise progression must be followed to get the athlete safely back on the field.
CDC Expert Commentary, November 2011
- Herpes Zoster: Who's at Risk and Who Should be Vaccinated Who should, and who should not, receive the zoster vaccine is clarified in this brief update from the CDC.
CDC Expert Commentary, November 2011
- Stopping the Hospital Spread of Gram-Negative Bacilli With the bottom of the beta-lactam barrel clearly visible, these strategies to halt transmission are imperative.
CDC Expert Commentary, November 2011
- When to Consider Cholera This most severe form of diarrheal illness has been imported to the United States. Make sure you know how to respond if you suspect cholera.
CDC Expert Commentary, November 2011
- Pharmacogenomics and Your Practice: Abacavir Pharmacogenomic tests, to predict patients' response to drugs, are slowly becoming available for use in clinical practice.
CDC Expert Commentary, November 2011
- CDC's Epi Info 7: A Useful Application for Clinicians, Too! Don't think Epi Info offers value to your clinical practice? Think again. Learn about how this tool's usefulness goes beyond its application to outbreak investigations and disease surveillance.
CDC Expert Commentary, November 2011
- Tdap: Now for Pregnant Women and 65 Plus The latest recommendations aim to cocoon young infants with protection from pertussis by vaccinating parents and grandparents.
CDC Expert Commentary, October 2011
- Protect Outpatient Oncology Patients From Infections One thing 1 million patients undergoing treatment for cancer don't need is an avoidable infection.
CDC Expert Commentary, October 2011
- Hereditary Breast and Ovarian Cancer: BRCA and Your Patient This information will help you identify which patients are at increased risk for breast or ovarian cancer, and those who may benefit from genetic counseling and testing.
CDC Expert Commentary, October 2011
- Mucormycosis: When to Think Fungal Infection An outbreak of mucormycosis occurred after the recent tornadoes in Joplin, Missouri. Would you have diagnosed these infections?
CDC Expert Commentary, October 2011
open here please:
CDC Expert Commentary
No hay comentarios:
Publicar un comentario